Seeking AlphaThu, 14 May 2026 03:00:45 GMTRhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 TranscriptRYTM-2.61%
BenzingaWed, 06 May 2026 18:04:59 GMTRhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 ResultsRYTM-2.61%
Seeking AlphaTue, 05 May 2026 21:31:20 GMTRhythm Pharmaceuticals, Inc. (RYTM) Q1 2026 Earnings Call TranscriptRYTM-2.61%
Zacks Investment ResearchTue, 05 May 2026 13:26:14 GMTRhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue EstimatesRYTM-2.61%
Zacks Investment ResearchWed, 29 Apr 2026 15:02:43 GMTSarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings GrowthRYTM-2.61%
Zacks Investment ResearchTue, 28 Apr 2026 15:06:43 GMTAnalysts Estimate Rhythm Pharmaceuticals, Inc. (RYTM) to Report a Decline in Earnings: What to Look Out forRYTM-2.61%
Zacks Investment ResearchWed, 01 Apr 2026 13:10:28 GMTStrength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?RYTM-2.61%
The Motley FoolTue, 31 Mar 2026 20:00:00 GMTIs This Weight Loss Drug Stock a Buy After a New Approval?RYTM-2.61%
Investors Business DailyFri, 20 Mar 2026 13:23:55 GMTRhythm Surges On A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat'RYTM-2.61%
Seeking AlphaFri, 20 Mar 2026 07:32:19 GMTRhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity TranscriptRYTM-2.61%
Investors Business DailyTue, 17 Mar 2026 14:11:48 GMTRhythm Pharmaceuticals Misses The Beat In Obesity, But There's A CaveatRYTM-2.61%
Seeking AlphaTue, 17 Mar 2026 06:02:17 GMTRhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial TranscriptRYTM-2.61%
Seeking AlphaThu, 26 Feb 2026 20:08:20 GMTRhythm Pharmaceuticals, Inc. (RYTM) Q4 2025 Earnings Call TranscriptRYTM-2.61%
Zacks Investment ResearchThu, 26 Feb 2026 15:56:04 GMTRhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue EstimatesRYTM-2.61%
